Partner Ryan Million, PhD and Consultant Rachel Chizkov recently published an article titled: Trends in breakthrough therapy designation. Breakthrough therapy designation was established by the FDA 3 years ago to help speed the review of products that treat serious medical conditions and unmet medical needs. The article examines whether this relatively new designation affects competition within various markets and its future outlook. The article is available for purchase through Nature’s website, here. To learn more about Dr. Ryan Million and our other partners, click here.